Parkinson's disease associated mutations in leucine rich repeat kinase 2 (LRRK2) impair mitochondrial function and increase the vulnerability of induced pluripotent stem cell (iPSC)-derived neural cells from patients to oxidative stress. Since mitochondrial DNA (mtDNA) damage can compromise mitochondrial function, we examined whether LRRK2 mutations can induce damage to the mitochondrial genome. We found greater levels of mtDNA damage in iPSC-derived neural cells from patients carrying homozygous or heterozygous LRRK2 G2019S mutations, or at-risk individuals carrying the heterozygous LRRK2 R1441C mutation, than in cells from unrelated healthy subjects who do not carry LRRK2 mutations. After zinc finger nuclease-mediated repair of the LRRK2 G2019S mutation in iPSCs, mtDNA damage was no longer detected in differentiated neuroprogenitor and neural cells. Our results unambiguously link LRRK2 mutations to mtDNA damage and validate a new cellular phenotype that can be used for examining pathogenic mechanisms and screening therapeutic strategies.
Introduction
Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with sporadic and familial forms of Parkinson's disease (PD) (Paisan-Ruiz et al., 2004; Satake et al., 2009; Simon-Sanchez et al., 2009; Zimprich et al., 2004) . Mitochondrial impairment is considered to be a critical factor in the pathogenesis of both sporadic and genetic forms of PD (Henchcliffe and Beal, 2008) . Recently, using PD patient-specific induced-pluripotent stem cells (iPSCs) carrying LRRK2 G2019S and R1441C mutations, both LRRK2 mutations were linked to compromised oxidative phosphorylation and mitochondrial dynamics, rendering neural cells more vulnerable to mitochondria-associated stress (Cooper et al., 2012) . However, the mechanisms by which LRRK2 mutations lead to a loss of mitochondrial function are poorly understood.
In PD, reactive oxygen species (ROS) damage lipids and proteins (Sherer and Greenamyre, 2005), but less is known about damage to mtDNA (Sanders and Greenamyre, 2013) . DNA damage, defined as any modification of DNA that can alter its coding properties or interfere with normal function in transcription or replication (Lindahl, 1993; Rao, 1993) , is distinct from mutations, which are a change in the base sequence of the DNA. However, damage to mtDNA may lead to mtDNA mutations. The mitochondrial genome is particularly susceptible to oxidative damage, likely due to the proximity of mtDNA to ROS production at the inner mitochondrial membrane and the lack of protection afforded by histones (Yakes and Van Houten, 1997) . Mitochondrial DNA damage can compromise metabolic functions, predispose to ROS generation and trigger cell death. Accumulation of mtDNA damage is a particular problem for the brain because neurons are post-mitotic and long-lived. In order to study these issues in a neuronal context, we applied cellular reprogramming technology to examine whether LRRK2 mutations lead to mtDNA damage.
